Fiona Karet

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada.

Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.

Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto.

Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA.

Part of Herschend Family Entertainment Corp., Vancouver Aquarium operates an aquarium. The company is based in Vancouver, Canada. Vancouver Aquarium was acquired by Herschend Family Entertainment Corp. from Ocean Wise Conservation Association on April 15, 2021. The Canadian company was founded in 1951.

AudienceView Ticketing Corp. engages in the provision and development of software and media solutions for ticket sales. It offers services through its platform, which under the brands of OvationTix, Vendini, TheaterMania, WhatsOnStage, LaughStub, ElectroStub, and TuneStub. The company was founded by Kevin Kimsa and Paul J. Atkinson in 2002 and is headquartered in Toronto, Canada.

Augurex Life Sciences Corp. develops biomarkers that transform patient clinical management. Its biomarkers substances in the body that inform patient conditions and assist with diagnosis, treatment and disease monitoring. The company’s first biomarker Extracellular 14-3-3eta protein, serves as a drug target for the potential treatment of rheumatoid arthritis (RA). Augurex Life Sciences was founded by Norma K. Biln and Anthony Marotta in October 2007 and is headquartered in Vancouver, Canada.

Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.

Five Corners Capital Inc (Five Corners Capital) is a venture capital firm founded in 2013 by Kenneth Galbraith and Gary Bridger. The firm is headquartered in British Columbia, Canada.

Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates.

Prometic Plasma Resources (USA), Inc. is based in Albany, NY. Part of KEDRION HOLDING S.P.A., Prometic Plasma Resources (USA), Inc. is a company that manufactures and distributes biopharmaceutical products. The CEO of the company is Kenneth Harry Galbraith.

Fairhaven Pharmaceuticals, Inc. engages in the research and development of small molecule antagonists that target chemoattractant and activator of eosinophils, which play a key role in type 2 inflammation-driven diseases. The company was founded on May 4, 2018 and is headquartered in Laval, Canada.